| Literature DB >> 30153883 |
Alessandro Miglietta1,2,3, Cecilia Fazio2,4, Arianna Neri2,4, Patrizio Pezzotti2, Francesco Innocenti1, Chiara Azzari5, Gian Maria Rossolini6, Maria Moriondo5, Francesco Nieddu5, Stefania Iannazzo7, Fortunato D'Ancona2,7, Francesco Paolo Maraglino7, Raniero Guerra7, Giovanni Rezza2, Fabio Voller1, Paola Stefanelli2.
Abstract
In 2015 an increased incidence of invasive meningococcal disease due to serogroup-C (MenC) occurred in Tuscany, Italy. This led the Regional Health Authority of Tuscany to implement a reactive immunisation campaign and to launch an epidemiological field investigation aiming to address targeted immunisation interventions. In 2011-14, 10 MenC cases had been reported compared with 62 cases in 2015-16. The case fatality rate was 21% (n = 13) and 51 cases (82.3%) were confirmed as C:P1.5-1,10-8:F3-6:ST-11(cc11). Overall, 17 clusters were recognised. Six discos and four gay-venues were found to have a role as transmission-hotspots, having been attended by 20 and 14 cases in the 10 days before symptoms onset. Ten and three cases occurred, respectively, among men who have sex with men (MSM) and bisexual individuals, who were involved in 11 clusters. In addition, heterosexual cases (n = 5) attending gay-venues were also found. Secondary cases were not identified. Molecular typing indicated close relationship with MenC clusters recently described among gay, bisexual and other MSM in Europe and the United States, suggesting a possible international spread of the serogroup-C-variant P1.5-1,10-8:F3-6:ST-11(cc11) in this population-group; however, epidemiological links were not identified. In December 2016, a targeted vaccination campaign involving discos and lesbian, gay, bisexual, and transgender (LGBT) associations was implemented. During 2017, 10 cases of MenC occurred, compared with 32 and 30 cases reported in 2015 and 2016 respectively, suggesting the effectiveness of the reactive and targeted immunisation programmes.Entities:
Keywords: clusters; invasive meningococcal disease serogroup C; men who have sex with men (MSM)
Mesh:
Substances:
Year: 2018 PMID: 30153883 PMCID: PMC6113744 DOI: 10.2807/1560-7917.ES.2018.23.34.1700636
Source DB: PubMed Journal: Euro Surveill ISSN: 1025-496X
Figure 1Number of serogroup C meningococcal disease cases by month and molecular characterisation, Tuscany, Italy, 1 January 2015–31 December 2016 (n = 62)
Figure 2Neighbour-net phylogenetic network of the bacterial isolates collected from meningococcal serogroup C cases, Tuscany, Italy, 2015–2016 (n = 30)
Crude and adjusted odds ratios of having a recognised risk factor for invasive meningococcal disease (IMD), by sexual behaviour/orientation, age group and sex among the IMD serogroup C outbreak-cases aged 11–70 years, Tuscany, Italy, 2015–2016 (n = 52)a
| IMD risk factor | Age group in years | Sex | Sexual-behaviour/orientation | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 11–25 | 26–40 | 41–55 | 56–70 | Female | Male | Heterosexual | MSM/bisexual | ||
| Active | Yes; N (%) | 14 (70.0) | 12 (75.0) | 5 (83.3) | 7 (70.0) | 21 (75.0) | 17 (70.8) | 26 (66.7) | 12 (92.3) |
| No; N (%) | 6 (30.0) | 4 (25.0) | 1 (16.7) | 3 (30.0) | 7 (25.0) | 7 (29.2) | 13 (33.3) | 1 (7.7) | |
| OR | Ref | 1.28 | 2.14 | 1.10 | Ref | 0.80 | Ref | 3.12 | |
| p-value | Ref | 0.74 | 0.52 | 0.40 | Ref | 0.73 | Ref | 0.11 | |
| Passive | Yes; N (%) | 6 (30.0) | 3 (18.7) | 0 (0.0) | 1 (10.0) | 4 (14.3) | 6 (25.0) | 7 (17.9) | 3 (23.1) |
| No; N (%) | 14 (70.0) | 13 (81.3) | 6 (100) | 9 (90.0) | 24 (85.7) | 18 (75.0) | 32 (82.1) | 10 (76.9) | |
| OR | Ref | 1.28 | N.E. | 1..34 | Ref | 2.13 | Ref | 1.37 | |
| p-value | Ref | 0.74 | N.E. | 0.64 | Ref | 0.33 | Ref | 0.54 | |
| Illicit | Yes; N (%) | 8 (40.0) | 8 (50.0) | 1 (16.7) | 1 (10.0) | 5 (17.9) | 13 (54.2) | 8 (20.5) | 10 (76.9) |
| No; N (%) | 12 (60.0) | 8 (50.0) | 5 (83.3) | 9 (90.0) | 23 (82.1) | 11 (45.8) | 31 (79.5) | 3 (23.1) | |
| OR | Ref | 1.50 | 0.31 | 0.16 | Ref | 5.43 | Ref | 6.91 | |
| p-value | Ref | 0.54 | 0.31 | 0.11 | Ref | < 0.01 | Ref | < 0.01 | |
| AOR (95%CI) | N.I. | N.I. | N.I. | N.I. | Ref | 3.41 | Ref | 4.56 | |
| p-value | N.I. | N.I. | N.I. | N.I. | Ref | 0.08 | Ref | < 0.01 | |
| Disco | Yes; N (%) | 11 (55.0) | 8 (50.0) | 1 (16.7) | 0 (0.0) | 8 (28.6) | 12 (50.0) | 14 (35.9) | 6 (46.1) |
| No; N (%) | 9 (45.0) | 8 (50.0) | 5 (83.3) | 10 (100) | 10 (71.4) | 12 (50.0) | 25 (64.1) | 7 (53.9) | |
| OR | Ref | 3.31 | 0.10 | N.E. | Ref | 1.80 | Ref | 4.51 | |
| p-value | Ref | 0.36 | 0.09 | N.E. | Ref | 0.30 | Ref | 0.02 | |
| Gay-venues | Yes; N (%) | 8 (40.0) | 6 (37.5) | 0 (0.0) | 0 (0.0) | 2 (7.2) | 12 (50.0) | 5 (12.8) | 9 (69.2) |
| No; N (%) | 12 (60.0) | 10 (62.5) | 6 (100) | 10 (100) | 26 (92.8) | 12 (50.0) | 34 (87.2) | 4 (30.8) | |
| OR | Ref | 0.77 | N.E. | N.E. | Ref | 8.47 | Ref | 9.34 | |
| p-value | Ref | 0.74 | N.E. | N.E. | Ref | 0.01 | Ref | < 0.01 | |
| AOR (95%CI) | N.I. | N.I. | N.E. | N.E. | Ref | 4.12 | Ref | 6.23 | |
| p-value | N.I. | N.I. | N.E. | N.E. | Ref | < 0.01 | Ref | < 0.01 | |
| Bar/restaurants attendanceb,c | Yes; N (%) | 15 (75.0) | 12 (75.0) | 6 (100) | 7 (70.0) | 21 (75.0) | 19 (79.2) | 28 (71.8) | 12 (92.3) |
| No; N (%) | 5 (25.0) | 4 (25.0) | 0 (0.0) | 3 (30.0) | 7 (25.0) | 5 (20.8) | 11 (28.2) | 1 (7.7) | |
| OR | Ref | 1.11 | N.E. | 0.77 | Ref | 1.26 | Ref | 5.33 | |
| p-value | Ref | 0.49 | N.E. | 0.77 | Ref | 0.72 | Ref | 0.12 | |
| Sharing | Yes; N (%) | 8 (40.0) | 5 (31.3) | 1 (16.7) | 1 (10.0) | 8 (28.6) | 7 (29.2) | 8 (20.5) | 7 (53.8) |
| No; N (%) | 12 (60.0) | 11 (68.7) | 5 (83.3) | 9 (90.0) | 20 (71.4) | 17 (70.8) | 31 (79.5) | 6 (46.2) | |
| OR | Ref | 0.68 | 0.30 | 0.16 | Ref | 1.02 | Ref | 4.52 | |
| p-value | Ref | 0.58 | 0.31 | 0.11 | Ref | 0.96 | Ref | 0.02 | |
| Clinical | Yes; N (%) | 0 (0.0) | 1 (6.3) | 0 (0.0) | 2 (20.0) | 1 (3.6) | 2 (8.3) | 2 (5.1) | 1 (7.7) |
| No; N (%) | 20 (100) | 15 (93.7) | 6 (100) | 8 (80.0) | 27 (96.4) | 22 (91.7) | 37 (94.9) | 12 (92.3) | |
| OR | Ref | 0.26 | N.E. | 0.34 | Ref | 2.54 | Ref | 1.54 | |
| p-value | Ref | 0.31 | N.E. | 0.56 | Ref | 0.47 | Ref | 0.73 | |
| Sexual | Yes; N (%) | 3 (15.0) | 5 (31.3) | 1 (16.7) | 2 (20.0) | 5 (17.9) | 6 (25.0) | 5 (12.8) | 6 (46.2) |
| No; N (%) | 17 (85.0) | 11 (68.7) | 5 (83.3) | 8 (80.0) | 23 (82.1) | 18 (75.0) | 34 (87.2) | 7 (53.8) | |
| OR | Ref | 1.88 | 1.13 | 1.14 | Ref | 1.21 | Ref | 3.83 | |
| p-value | Ref | 0.45 | 0.92 | 0.73 | Ref | 0.78 | Ref | 0.01 | |
AOR: adjusted odds ratios; IMD: invasive meningococcal disease; N.E.: not estimable; N.I.: not included; OR: odds ratio; Ref: reference value.
a Five cases aged under 10 years and four over 70 years were excluded from this analysis, plus one case who did not participate in the face-to-face interview.
b Multivariable analysis not performed because p > 0.05 at the univariate analysis.
c In the 10 days before symptom onset.
Figure 3Social network diagram showing epidemiological links between serogroup C meningococcal disease cases, contacts, places and interconnections between clusters, Tuscany, 2015–2016 (n = 49)a